QNCX Stock Summary and Trading Ideas (Quince Therapeutics | NASDAQ:QNCX)

Quince Therapeutics Inc is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. Its proprietary AIDE technology is an inventive drug/device combination platform that uses an automated process to encapsulate a drug into a patient's own red blood cells. Its Phase 3 asset, eDSP, leverages the AIDE technology to encapsulate DSP into a patient's own red blood cells, and is targeted to treat a rare pediatric neurodegenerative disease, A-T.

Quince Therapeutics trades on the NASDAQ stock market under the symbol QNCX.

As of September 30, 2026, QNCX stock price declined to $31.01 with 10,476 million shares trading.

QNCX has a beta of 2.36, meaning it tends to be more sensitive to market movements. QNCX has a correlation of 0.01 to the broad based SPY ETF.

QNCX has a market cap of $31.54 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, QNCX traded as high as $909.98 and as low as $15.10.

The top ETF exchange traded funds that QNCX belongs to (by Net Assets): VXF.

QNCX has underperformed the market in the last year with a return of -90.4%, while SPY returned +16.1%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in QNCX shares. However, QNCX has outperformed the market in the last 3 month and 2 week periods, returning +68.4% and +7.5%, while SPY returned +3.2% and +0.9%, respectively. This indicates QNCX has been having a stronger performance recently.

QNCX support price is $29.08 and resistance is $33.26 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that QNCX shares will trade within this expected range on the day.